They reported that circCCNB1 silencing which acted as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression and activation of the AKT/ERK signaling pathway in vivo and in vitro [14]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.